Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction

This publication has 25 references indexed in Scilit:

• Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir*
  Clinical Pharmacology & Therapeutics, 1998
• The effect of multiple doses of ritonavir on the pharmacokinetics of rifabutin*
  Clinical Pharmacology & Therapeutics, 1998
• Clinically effective HIV-1 protease inhibitors
  Drug Discovery Today, 1997
• Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes: Major role of CYP3A
  Biochemical Pharmacology, 1997
• [15] Use of tolbutamide as a substrate probe for human hepatic cytochrome P450 2C9
  Published by Elsevier ,1996
• Measurement of Liver Microsomal Cytochrome P450 (CYP2D6) Activity Using [O-methyl-14C] Dextromethorphan
  Analytical Biochemistry, 1994
• Selective Inhibitors of Cytochromes P450
  Toxicology and Applied Pharmacology, 1994
• Isolation and Characterization of Human Liver Cytochrome P450 2C19: Correlation between 2C19 and S-Mephenytoin 4′-Hydroxylation
  Archives of Biochemistry and Biophysics, 1993
• Enzyme induction in the cytochrome P-450 system
  Pharmacology & Therapeutics, 1990